3 months ago
TEVA
AnalystsLes SulewskiLes Sulewski's Stock Forecasts
AnalystsLes Sulewski
Sectors:
Analyst Ranking
Bottom 9%
#4901 out of 5342 analysts
Average Return
-9.4%
Win Rate
44%8 out of 18
Risk vs Reward
Poor
Good
Les Sulewski's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | +90.41% | $18.15 | $34.56 | 2025-05-28 - 2026-05-27 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +33.04% | $13.77 | $18.32 | 2026-03-02 - 2026-07-31 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +20.84% | $8.59 | $10.38 | 2024-10-02 - 2025-10-01 | Strong Buy |
Pacira Biosciences IncPCRX | +19.77% | $22.05 | $26.41 | 2025-11-07 - 2026-07-31 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +17.24% | $7.54 | $8.84 | 2024-08-12 - 2025-08-11 | Strong Buy |
Les Sulewski Analyst Color
Get additional color on Les Sulewski's coverage of popular stocks
Les Sulewski's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | 4 | Strong Buy | $45.00 | +28.53% | Maintains | 3 months ago |
Vanda Pharmaceuticals IncVNDA | 1 | Strong Buy | $18.00 | +252.94% | Initiates Coverage On | 5 months ago |
Amneal Pharmaceuticals IncAMRX | 4 | Strong Buy | $17.00 | -7.21% | Maintains | 5 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | +16.11% | Maintains | 7 months ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $28.00 | +6.02% | Maintains | 9 months ago |
Collegium Pharmaceutical IncCOLL | 3 | Strong Buy | $48.00 | +35.63% | Maintains | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.